In 2009, everybody can get his or
her individual genome scanned - for disease, for ancestry, for recreation.
Not exact matches
Using an approach called a
genome - wide association study, researchers
scanned complete sets of DNA in thousands of participants, looking for small variations that appear more often in people with the disease than in healthy
individuals.
While several studies in the intervening years have investigated whether particular genes were responsible for modifying HD onset, this is the first to employ
genome - wide association (GWA) analysis, which
scans an
individual's whole
genome to identify chromosomal regions containing variants that are associated with the disease traits that are being studied.
Falling well short of full
genome analyses, these services
scan an
individual's DNA for single nucleotide polymorphisms — point mutations — that are linked to traits and diseases.
In the new study, which appears in Cell today, the researchers scrutinized the DNA of five
individuals from each group,
scanning each
genome an average of 60 times.
In the study, geneticist Sarah Tishkoff of the University of Pennsylvania and colleagues
scanned the entire
genomes of about 70
individuals from three pygmy groups in Cameroon, and another 60 from three neighboring Bantu groups (tall, thin, farming tribes with whom pygmies have intermarried for generations).
The same staff and facility also process deCODE's DNA - based reference laboratory tests for gauging
individual risk of major public health challenges ranging from heart attack to breast cancer, as well as the company's pioneering deCODEme ™
scans, the world's first personal
genome analysis and focused disease area
scans.
That framework can then be used to
scan genomic data from multiple
individuals and compute the probabilities that
individual mutations or regions of a
genome are adaptive.
deCODE will employ its CLIA - registered genotyping laboratory and existing testing platform to swiftly integrate the finding into its deCODEme ™ personal
genome scan, and to assess the addition of this new variant to the company's deCODE T2 ™ reference laboratory test for assesing
individual risk of type 2 diabetes.
First, the SNPs with the best results from previous
genome - wide
scans of more than 300,000 SNPs were tested in large numbers of
individuals with and without BCC.
Latest discoveries add to understanding of
individual risk of basal cell carcinoma, and are integrated into the deCODEme ™ personal
genome analysis
scan Reykjavik, ICELAND, October 13, 2008 — Scientists at deCODE genetics (Nasdaq: DCGN) today report the discovery of...
She is
scanning the
genomes of
individuals in the current study to identify regions that may contain additional gene candidates.